Adma Biologics, Inc. Income Statement

Income Statement Dec2011 Dec2012 Dec2015 Dec2016 Dec2017 Dec2018 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.76M1.12M7.18M10.66M22.76M16.99M42.22M80.94M154.08M258.21M426.45M
Cost of Revenue 1.16M1.75M4.62M6.36M29.16M42.19M61.29M79.77M118.81M169.27M206.90M
Gross Profit 0.55M0.45M2.56M4.30M-6.40M-25.21M-19.07M1.17M35.27M88.94M219.55M
Operating items
Amortization - Intangibles 1.23M0.84M0.72M0.71M0.71M0.72M0.40M
Research & Development 0.65M3.47M7.02M7.69M5.57M3.93M5.91M3.65M3.61M3.30M1.81M
Selling, General & Administrative 1.43M3.14M6.75M8.49M18.75M22.50M35.05M42.90M52.46M59.02M74.12M
Other Operating Expenses 3.10M1.75M8.93M11.81M37.75M50.85M4.89M13.00M18.56M4.99M4.63M
Operating Expenses 5.18M8.36M22.69M27.99M62.07M77.27M45.84M59.55M74.63M67.31M80.57M
Operating Income -4.62M-7.91M-15.51M-17.33M-39.31M-60.29M-64.91M-58.37M-39.37M21.63M138.98M
EBIT -4.62M-7.91M-15.51M-17.33M-39.31M-60.29M-64.91M-58.37M-39.37M21.63M138.98M
Non-operating items
Non Operating Investment Income 0.07M
Interest & Investment Income 0.00M0.02M0.04M0.05M0.06M0.20M0.29M0.04M0.04M1.62M2.10M
Other Non Operating Income -0.72M0.00M-1.21M-0.13M0.99M-0.25M-6.67M-26.17M4.34M
Non Operating Income -2.46M-2.18M-4.45M-5.45M-11.83M-13.27M-26.54M-49.87M-13.27M
Net income details
EBT -6.22M-7.92M-17.32M-19.52M-42.54M-65.62M-76.61M-71.40M-65.90M-28.24M125.71M
Tax Provisions -0.32M-0.62M-71.96M
Profit After Tax -5.90M-7.30M-17.32M-19.52M-42.54M-65.62M-75.75M-71.65M-65.90M-28.24M197.67M
Income from Continuing Operations -5.90M-7.30M-17.32M-19.52M-42.54M-65.62M-76.61M-71.40M-65.90M-28.24M197.67M
Consolidated Net Income -5.90M-7.30M-17.32M-19.52M-42.54M-65.62M-76.61M-71.40M-65.90M-28.24M197.67M
Income towards Parent Company -5.90M-7.30M-17.32M-19.52M-42.54M-65.62M-76.61M-71.40M-65.90M-28.24M197.67M
Net Income towards Common Stockholders -5.90M-7.30M-17.32M-19.52M-42.54M-65.62M-76.61M-71.40M-65.90M-28.24M197.67M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M0.00M
Shares Outstanding (Weighted Average) 4.62M10.71M12.89M39.41M46.35M94.55M195.81M196.78M225.97M236.39M
Shares Outstanding (Diluted Average) 86.15M139.58M197.87M223.98M243.34M
EBITDA -4.62M-7.91M-15.51M-17.33M-39.31M-60.29M-64.91M-58.37M-39.37M21.63M138.98M
Tax Rate 5.15%7.80%